Solstice Advanced Materials (SOLS)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$63.73+3.85%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · SOLS
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $64 SOLS trades at 28× p/e — 1.6× the 17× p/e peer median. The market is re-rating it beyond its own range; our $51 fair value is medium-confidence here. Analysts target $48–$102. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $86.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $43.38 | — | — | Analyst | high |
| dcf fcff | 12M | $68.33 | — | — | Analyst | high |
| graham number | 12M | $22.79 | — | — | TTM | high |
| Peer P/FCF | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$48.00 – $102.00 (median $86.00) · 15 analysts · as of 2026-09-03
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $23.81 |
| 21.1 |
| 1.13 |
| TTM |
| high |
| Peer P/E | 12M | $40.22 | 17.4 | 2.32 | TTM | high |
| Peer P/S | 12M | $37.22 | 1.4 | 25.69 | TTM | high |
| PEG | 12M | $56.53 | 24.4 | 2.32 | TTM | high |
| residual income | 12M | $15.34 | — | — | TTM | high |
| triangulated | 12M | $42.00 | 17.4 | 2.42 | Triangulated | high |
| Peer P/E | 3Y | $61.17 | 17.4 | 3.52 | Analyst | medium |
| Peer P/S | 3Y | $41.11 | 1.4 | 28.37 | guidance | medium |
| PEG | 3Y | $85.97 | 24.4 | 3.52 | Analyst | medium |
| Peer P/E | 5Y | $80.89 | 17.4 | 4.66 | Analyst | medium |
| Peer P/S | 5Y | $42.32 | 1.4 | 29.21 | guidance | medium |
| PEG | 5Y | $113.70 | 24.4 | 4.66 | Analyst | medium |